Aurora Cannabis has acquired MedReleaf Australia for A$50 million in a cash and share deal. The acquisition, which includes $9.45 million in cash and the rest in Aurora shares, will strengthen Aurora’s position in the rapidly growing Australian medical cannabis market. MedReleaf Australia generated approximately $40 million in revenue in 2023, capturing one in five medicinal cannabis sales in Australia.
Read the full story here
Written by: Steve Jones
Published on February 9, 2024 at 08:59AM
Source: Cannabiz (opens in new tab)